Trust Point’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Trust Point's GILD Position: Q3 2026 in Review
Trust Point increased its Gilead Sciences (GILD) stake by 18% in Q3 2026, buying an estimated $87.6K and bringing the position to 4,129 shares worth $615K. The position accounts for 0.05% of the portfolio, ranked #217.
Trust Point first reported a position in GILD in Q4 2023 and has held it in 12 quarters since. 2,060 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Trust Point held 4,129 shares of Gilead Sciences worth $615K as of Q3 2026.
- Trust Point bought 624 Gilead Sciences shares in Q3 2026, an estimated $87.6K.
- Gilead Sciences made up 0.05% of Trust Point's portfolio in Q3 2026, its #217 holding.
- Trust Point first reported a position in Gilead Sciences in Q4 2023 and has held it in 12 quarters since.
- 2,060 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.